Greenwich Stock Buy Hold or Sell Recommendation

GLSI -  USA Stock  

USD 8.66  0.24  2.70%

Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Greenwich Lifesciences is 'Strong Hold'. Macroaxis provides Greenwich Lifesciences buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding GLSI positions. The advice algorithm takes into account all of Greenwich Lifesciences' available fundamental, technical, and predictive indicators you will find on this site.
  
Refresh
The advice is provided from Greenwich Lifesciences' buy-and-hold perspective. Please check Greenwich Lifesciences Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. We conduct extensive research on individual companies such as Greenwich and provide practical buy, sell, or hold advice based on selected investing horizon and risk tolerance towards Greenwich Lifesciences.

Execute Greenwich Lifesciences Buy or Sell Advice

The Greenwich recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Greenwich Lifesciences. Macroaxis does not own or have any residual interests in Greenwich Lifesciences or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Greenwich Lifesciences' advice using the current market data and latest reported fundamentals.

Time Horizon

Risk Tolerance

Execute Advice
Sell Greenwich LifesciencesBuy Greenwich Lifesciences
Strong Hold

Volatility

Very riskyDetails

Hype Condition

Under hypedDetails

Current Valuation

UndervaluedDetails

Odds of Distress

Quite HighDetails

Economic Sensitivity

Slowly supersedes the marketDetails

Analyst Consensus

Strong BuyDetails

Financial Strenth (F Score)

FrailDetails

Financial Leverage

InapplicableDetails

Reporting Quality (M-Score)

Unlikely ManipulatorDetails
For the selected time horizon Greenwich Lifesciences has a Risk Adjusted Performance of (0.33), Jensen Alpha of (0.91), Total Risk Alpha of (0.58) and Treynor Ratio of (0.83)
We provide advice to complement the regular expert consensus on Greenwich Lifesciences. Our dynamic recommendation engine utilizes a multidimensional algorithm to analyze the company's potential to grow using all technical and fundamental data available at the time. To make sure Greenwich Lifesciences is not overpriced, please check out all Greenwich Lifesciences fundamentals, including its price to book, as well as the relationship between the total debt and earnings per share . Given that Greenwich Lifesciences has a cash and equivalents of 27.2 M, we strongly advise you to confirm Greenwich Lifesciences market performance and probability of bankruptcy to ensure the company can sustain itself in the current economic cycle given your regular risk tolerance and investing horizon.

Greenwich Lifesciences Trading Alerts and Improvement Suggestions

Greenwich Lifesciences generated a negative expected return over the last 90 days
Greenwich Lifesciences has high historical volatility and very poor performance
Greenwich Lifesciences has high likelihood to experience some financial distress in the next 2 years
Net Loss for the year was (4.57 M).
Greenwich Lifesciences currently holds about 27.2 M in cash with (4.29 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.1.
Greenwich Lifesciences has a frail financial position based on the latest SEC disclosures
Roughly 78.0% of the company shares are held by company insiders
Latest headline from seekingalpha.com: Greenwich LifeSciences A First Look - Seeking Alpha

Greenwich Lifesciences current analysts advice

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Greenwich analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Greenwich analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target Mean Price78.00
Target Median Price78.00
Target High Price78.00
Recommendation Mean2.00
Number Of Analyst Opinions1
Target Low Price78.00
The consensus estimates and target price estimation comprises individual analyst assessments, and may or may not mutch the Macroaxis buy or sell advice. It is determined by taking an average of all analyst recommendations and classifying them as Strong Buy, Buy, Hold, or Sell.

Greenwich Lifesciences Returns Distribution Density

The distribution of Greenwich Lifesciences' historical returns is an attempt to chart the future uncertainty of Greenwich Lifesciences' future price movements. The chart of the probability distribution of Greenwich Lifesciences stock daily returns describes the distribution of returns around its average expected value. We use Greenwich Lifesciences price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Greenwich Lifesciences returns is essential to provide solid investment advice for Greenwich Lifesciences stock.
Mean Return-1.14Value At Risk-8.38
Potential Upside5.66Standard Deviation4.54
 Return Density 
      Distribution 
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Greenwich Lifesciences historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.

Greenwich Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Greenwich Lifesciences is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Greenwich Lifesciences backward and forwards among themselves. Greenwich Lifesciences' institutional investor refers to the entity that pools money to purchase Greenwich Lifesciences' securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Security TypeSharesValue
Vanguard Group IncCommon Shares375.2 K7.4 M
Blackrock IncCommon Shares236.3 K4.6 M
Geode Capital Management LlcCommon Shares69.7 K1.4 M
State Street CorpCommon Shares66.5 K1.3 M
Ameriprise Financial IncCommon Shares42.7 K837 K
Northern Trust CorpCommon Shares35.1 K688 K
Morgan StanleyCommon Shares21.7 K426 K
Note, although Greenwich Lifesciences' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Greenwich Lifesciences Greeks

Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Greenwich Lifesciences or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Greenwich Lifesciences stock's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Greenwich stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α
Alpha over DOW
-0.91
β
Beta against DOW1.38
σ
Overall volatility
4.60
Ir
Information ratio -0.22

Greenwich Lifesciences Volatility Alert

Greenwich Lifesciences exhibits very low volatility with skewness of -0.06 and kurtosis of -0.01. However, we advise investors to further study Greenwich Lifesciences technical indicators to make sure all market info is available and is reliable. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Greenwich Lifesciences' stock risk against market volatility during both bullying and bearish trends. The higher level of volatility that comes with bear markets can directly impact Greenwich Lifesciences' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different stocks as prices fall.

Greenwich Lifesciences Implied Volatility

Greenwich Lifesciences' implied volatility exposes the market's sentiment of Greenwich Lifesciences stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Greenwich Lifesciences' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Greenwich Lifesciences stock will not fluctuate a lot when Greenwich Lifesciences' options are near their expiration.

Greenwich Lifesciences Fundamentals Vs Peers

Comparing Greenwich Lifesciences' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Greenwich Lifesciences' direct or indirect competition across all of the common fundamentals between Greenwich Lifesciences and the related equities. This way, we can detect undervalued stocks with similar characteristics as Greenwich Lifesciences or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Greenwich Lifesciences' fundamental indicators could also be used in its relative valuation, which is a method of valuing Greenwich Lifesciences by comparing valuation metrics with those of similar companies.
    
 Better Than Average     
    
 Worse Than Average Compare Greenwich Lifesciences to competition
FundamentalsGreenwich LifesciencesPeer Average
Return On Equity(16.78) %(0.31) %
Return On Asset(10.28) %(0.14) %
Current Valuation126.27 M16.62 B
Shares Outstanding13.12 M571.82 M
Shares Owned by Insiders77.64 %10.09 %
Shares Owned by Institutions7.65 %39.21 %
Number of Shares Shorted298.3 K4.71 M
Price to Book3.95 X9.51 X
EBITDA(4.59 M)3.9 B
Net Income(4.57 M)570.98 M
Cash and Equivalents27.2 M2.7 B
Cash per Share2.10 X5.01 X
Total Debt635.15 K5.32 B
Current Ratio70.63 X2.16 X
Book Value Per Share2.19 X1.93 K
Cash Flow from Operations(4.29 M)971.22 M
Short Ratio4.86 X4.00 X
Earnings Per Share(0.27) X3.12 X
Number of Employees318.84 K
Market Capitalization113.65 M19.03 B
   Purchase by Daugherty Frank Joseph of 1000 shares of Greenwich Lifesciences [view details]

About Greenwich Lifesciences Buy or Sell Advice

When is the right time to buy or sell Greenwich Lifesciences? Buying financial instruments such as Greenwich Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the stock market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Although Greenwich Lifesciences investors may find it confusing at the beginning, most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
 2019 2020 2021 2022 (projected)
Current Assets6.83 K28.68 M27.22 M22.43 M
Total Assets26.67 K28.68 M27.22 M22.43 M

Use Investing Ideas to Build Portfolios

In addition to having Greenwich Lifesciences in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Corona Opportunity Thematic Idea Now

Corona Opportunity
Corona Opportunity Theme
Firms that are involved in some capacity in making products or providing services to the public to buttle the virus directly or indirectly. This also includes some defencive and contrarian stocks and ETFs that are managing to avoid the big market correction coused by coronavirus. The Corona Opportunity theme has 45 constituents.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Corona Opportunity Theme or any other thematic opportunities.
View All  Next Launch Corona Opportunity
Please check Greenwich Lifesciences Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note that the Greenwich Lifesciences information on this page should be used as a complementary analysis to other Greenwich Lifesciences' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try CEO Directory module to screen CEOs from public companies around the world.

Complementary Tools for Greenwich Stock analysis

When running Greenwich Lifesciences price analysis, check to measure Greenwich Lifesciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Greenwich Lifesciences is operating at the current time. Most of Greenwich Lifesciences' value examination focuses on studying past and present price action to predict the probability of Greenwich Lifesciences' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Greenwich Lifesciences' price. Additionally, you may evaluate how the addition of Greenwich Lifesciences to your portfolios can decrease your overall portfolio volatility.
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Go
Probability Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Go
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Go
Shere Portfolio
Track or share privately all of your investments from the convenience of any device
Go
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Go
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Go
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Go
Is Greenwich Lifesciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Greenwich Lifesciences. If investors know Greenwich will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Greenwich Lifesciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Greenwich Lifesciences is measured differently than its book value, which is the value of Greenwich that is recorded on the company's balance sheet. Investors also form their own opinion of Greenwich Lifesciences' value that differs from its market value or its book value, called intrinsic value, which is Greenwich Lifesciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Greenwich Lifesciences' market value can be influenced by many factors that don't directly affect Greenwich Lifesciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Greenwich Lifesciences' value and its price as these two are different measures arrived at by different means. Investors typically determine Greenwich Lifesciences value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Greenwich Lifesciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.